202 related articles for article (PubMed ID: 25881320)
1. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis.
Fourie JJ; Meyer L; Thomas E
Parasit Vectors; 2019 Jan; 12(1):59. PubMed ID: 30683143
[TBL] [Abstract][Full Text] [Related]
3. Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto
Rohdich N; Meyer L; Guerino F
Parasit Vectors; 2022 Mar; 15(1):83. PubMed ID: 35279216
[TBL] [Abstract][Full Text] [Related]
4. A European field assessment of the efficacy of fluralaner (Bravecto
Petersen I; Chiummo R; Zschiesche E; Karas-Tecza J; Rapti D; Roepke R; Thomas E
Parasit Vectors; 2020 Jun; 13(1):304. PubMed ID: 32527282
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate) against generalised demodicosis in dogs.
Fourie JJ; Delport PC; Fourie LJ; Heine J; Horak IG; Krieger KJ
Parasitol Res; 2009 Aug; 105 Suppl 1():S115-24. PubMed ID: 19575232
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.
Heine J; Krieger K; Dumont P; Hellmann K
Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281
[TBL] [Abstract][Full Text] [Related]
8. Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid.
Huang HP; Lien YH
Acta Vet Scand; 2013 May; 55(1):40. PubMed ID: 23663380
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis.
Beugnet F; Halos L; Larsen D; de Vos C
Parasite; 2016; 23():14. PubMed ID: 27012161
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats.
Taenzler J; de Vos C; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2017 Jan; 10(1):30. PubMed ID: 28093080
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
Krieger K; Heine J; Dumont P; Hellmann K
Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
[TBL] [Abstract][Full Text] [Related]
13. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.
Paterson TE; Halliwell RE; Fields PJ; Louw ML; Ball G; Louw J; Pinckney R
Vet Parasitol; 2014 Oct; 205(3-4):687-96. PubMed ID: 25262617
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix(®)) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs.
Jongejan F; Crafford D; Erasmus H; Fourie JJ; Schunack B
Parasit Vectors; 2016 Jun; 9(1):348. PubMed ID: 27317101
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs.
Kohler-Aanesen H; Saari S; Armstrong R; Péré K; Taenzler J; Zschiesche E; Heckeroth AR
Parasit Vectors; 2017 Sep; 10(1):426. PubMed ID: 28923117
[TBL] [Abstract][Full Text] [Related]
16. Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate(Bayer Animal Health) with ivermectin.
Paterson TE; Halliwell RE; Fields PJ; Louw ML; Louw JP; Ball GS; Pinckney RD; McKibben JS
Vet Dermatol; 2009 Oct; 20(5-6):447-55. PubMed ID: 20178483
[TBL] [Abstract][Full Text] [Related]
17. Treatment of canine generalized demodicosis with a 'spot-on' formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate, Bayer Healthcare).
Mueller RS; Meyer D; Bensignor E; Sauter-Louis C
Vet Dermatol; 2009 Oct; 20(5-6):441-6. PubMed ID: 20178482
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation.
Djuric M; Milcic Matic N; Davitkov D; Glavinic U; Davitkov D; Vejnovic B; Stanimirovic Z
Parasit Vectors; 2019 May; 12(1):270. PubMed ID: 31138280
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and duration of action of oral fluralaner and spot-on moxidectin/imidacloprid in cats infested with Lynxacarus radovskyi.
Han HS; Noli C; Cena T
Vet Dermatol; 2016 Dec; 27(6):474-e127. PubMed ID: 27870235
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of imidacloprid 10 per cent/moxidectin 2-5 per cent spot-on in the treatment of cheyletiellosis in dogs.
Loft KE; Willesen JL
Vet Rec; 2007 Apr; 160(15):528-9. PubMed ID: 17435103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
